Table 1.
Evidence Profile Table
Study Characteristic | Data |
---|---|
No. of randomized clinical trials | 16 |
Study years | Conducted, 2006-2016; published, 2008-2018 |
Date of literature search | 1940-July 23, 2018 |
No. of patients | 5,158 randomized; 5,000 analyzed |
Race/ethnicity | Unavailable |
Age | Adults |
Setting | ICUs |
Countries | Australia, Brazil, China, France, Germany, Netherlands, Serbia, Switzerland, USA |
Comparison | Procalcitonin-guided antibiotic discontinuation vs control group |
Primary outcome | Mortality (28-d mortality or hospital mortality) |
Secondary outcomes | Antibiotic duration and length of stay |